SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION vs Imbio RV/LV Software

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

by DIACOUSTIC MEDICAL DEVICES (PTY)

Imbio RV/LV Software

by Imbio

AI Verdict

These tools are adjacent rather than direct competitors, as they address different diagnostic pathways within cardiology. Tool A focuses on analyzing acoustic heart signals from stethoscopes to diagnose heart murmurs, while Tool B processes CTPA scans to measure ventricular diameters for risk stratification in pulmonary conditions. Their distinct input modalities (audio vs. imaging) and specific clinical applications make them suitable for different use cases.

Choose SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION if…

Choose SensiCardiac Mobi if your clinical practice requires an immediate, AI-assisted assessment of heart murmurs directly at the point of care using an electronic stethoscope. This tool is ideal for physicians in primary care, internal medicine, or pediatrics who need to quickly differentiate between physiological and pathological heart sounds to guide further diagnostic steps.

View SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION →

Choose Imbio RV/LV Software if…

Choose Imbio RV/LV Software if your radiology or cardiology department needs automated, quantitative analysis of CTPA scans for rapid risk stratification of patients. This software is best suited for environments where efficient and consistent measurement of right and left ventricular diameters is crucial for managing conditions like pulmonary embolism.

View Imbio RV/LV Software →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	Imbio RV/LV Software
Pricing	Contact for pricing	Subscription-based
Deployment	Hosted server environment (Linux OS) with a mobile application interface	Cloud-based (Imbio Cloud in AWS with Imbio Bridge), on-premise (Imbio Enterprise as a software-only VMware solution), or via partner platforms (e.g., Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel).
BAA Available	Yes AI-estimated	Unknown
FDA Status	1 AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Imbio RV/LV Software

Tool B offers a fully automated workflow that integrates directly into existing radiology environments (PACS), requiring no user intervention after scan completion. In contrast, Tool A, while mobile, requires active user interaction with an electronic stethoscope and a mobile application for data capture and display, which introduces more manual steps into the diagnostic process.

Clinical Value

Tie

Both tools provide significant clinical value in their respective domains. Tool A assists in the early diagnosis of heart murmurs, a critical step in cardiology and pediatrics. Tool B provides automated RV/LV ratio measurements for risk stratification in acute pulmonary conditions like pulmonary embolism, directly impacting urgent treatment decisions. Both are FDA-cleared and address important clinical needs.

Pricing & Value

Imbio RV/LV Software

Tool B provides more transparency regarding its pricing model, stating it is subscription-based and dependent on the number of analyses or installations. Tool A offers no public pricing information, requiring direct contact for details, which makes it harder for potential customers to assess its value proposition upfront.

Enterprise Readiness

Imbio RV/LV Software

Tool B demonstrates superior enterprise readiness with flexible deployment options including cloud, on-premise, and integration with multiple major partner platforms (e.g., Nuance, Siemens Syngo.via). Tool A's deployment appears more limited to a hosted server environment with a mobile application interface, offering less versatility for diverse enterprise IT infrastructures.

Innovation

SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION

Tool A presents a slightly more innovative application by bringing AI directly to the point of care for real-time heart murmur diagnosis using a mobile app and an electronic stethoscope, augmenting a traditional physical exam. While Tool B's automation of RV/LV measurements from CTPA scans is also innovative, Tool A's approach integrates AI into a fundamental, often subjective, clinical skill in a novel way.

Support & Docs

Tie

Neither the provided structured facts nor general web searches yielded specific, comparable information regarding the level of support or documentation available for either Tool A or Tool B. Without this information, it is not possible to distinguish between the two on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	Imbio RV/LV Software
Name	SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION	Imbio RV/LV Software
Company	DIACOUSTIC MEDICAL DEVICES (PTY)	Imbio
Primary Function	Assists physicians in diagnosing heart murmurs by analyzing acoustic heart signals from an electronic stethoscope to differentiate between physiological and pathological sounds.	Automatically measures right and left ventricular diameters from CTPA scans, providing a ratio to aid in risk stratification for pulmonary conditions like pulmonary embolism.
Target Specialties	Cardiology, Internal Medicine, Pediatrics	Cardiology, Pulmonology, Radiology
Key AI Application	AI-powered analysis of acoustic heart signals using the Sensi Diagnostic Heart Murmur Algorithm to distinguish between normal/physiological and pathological heart murmurs, identifying S1, S2, and suspected murmurs.	Artificial intelligence algorithm for automated identification and measurement of right and left ventricular diameters from CTPA scans.
Output/Deliverable	Mobile application for data capture and display (e.g., iPhone 4S or later), operates as decision support software complementing physician assessment.	Annotated images showing ventricular measurements, summary PDF reports, DICOM compliant input and output, integration with standard reading environments (PACS).

Videos

Demos, reviews, and walkthroughs featuring SENSICARDIAC MOBI DIAGNOSTIC HEART MURMUR APPLICATION and Imbio RV/LV Software.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How does SensiCardiac Mobi integrate into a physician's existing patient examination workflow for auscultation, and what is the typical learning curve?

SensiCardiac Mobi integrates by acquiring and recording acoustic heart signals using a compatible electronic stethoscope during a standard auscultation. The mobile application then analyzes these sounds to assist in diagnosis, complementing the physician's assessment. The learning curve primarily involves familiarization with the mobile app interface and interpreting the AI-generated differentiation between physiological and pathological murmurs, with usability testing showing positive user scores.

What is the depth of EHR integration for SensiCardiac Mobi, specifically regarding the transfer of heart sound recordings and diagnostic reports?

SensiCardiac Mobi operates as decision support software with a mobile application for data capture and display. While it records heart sounds and identifies murmurs, the provided information does not explicitly detail direct integration capabilities for transferring raw heart sound recordings or detailed diagnostic reports into a patient's electronic health record. However, some related platforms offer downloadable PDF reports and EHR integration.

What are the validated accuracy metrics for Imbio RV/LV Software's automated measurements, and how does it integrate with existing PACS and EHR systems?

Imbio RV/LV Software utilizes an artificial intelligence algorithm for automated ventricle identification and measurement, providing annotated images and summary PDF reports. Clinical performance validation has shown accuracy in measuring the RV/LV ratio compared to expert radiologists, with 97% of ratios within limits of agreement. It is DICOM compliant for input and output and integrates with standard reading environments (PACS), facilitating seamless data flow and automatically adding reports to the patient imaging study.

For multi-site practices, what are the considerations for rolling out SensiCardiac Mobi across different clinic locations and ensuring consistent usage?

SensiCardiac Mobi operates via a hosted server environment with a mobile application interface, requiring a compatible electronic stethoscope at each point of care. Multi-site rollout would involve ensuring each location has the necessary mobile devices and stethoscopes, and that users are trained on the application for consistent data capture and analysis. Some related platforms offer centralized user management for multiple facilities.

What specific clinical contexts or patient populations would most benefit from the use of SensiCardiac Mobi for heart murmur diagnosis?

SensiCardiac Mobi is designed to assist physicians in diagnosing heart murmurs by differentiating between physiological and pathological sounds, making it beneficial in cardiology, internal medicine, and pediatrics. It is particularly useful for enhancing the accuracy of auscultation in patients where heart murmurs are suspected or need further evaluation, and can help avoid unnecessary referrals.

How does Imbio RV/LV Software's fully automated workflow impact the time-to-value for a radiology department, and what kind of ongoing support is available?

Imbio RV/LV Software offers a fully automated workflow with no user intervention required after scan completion, which can significantly reduce manual measurement time and accelerate reporting. This automation contributes to a rapid time-to-value by streamlining the risk stratification process for pulmonary conditions, with results automatically available within minutes. Imbio provides support via email for algorithm malfunctions or performance changes.